Loading
The parathyroid hormone level used to diagnose and monitor CKD-MBD — targets rise with CKD stage.
PTH rises progressively in CKD (secondary hyperparathyroidism). KDIGO recommends trending PTH rather than fixed targets, with treatment (binders, vitamin D analogs, calcimimetics) when trends climb or complications appear. Calcium and phosphorus are interpreted with PTH.
Overactive parathyroid glands caused by kidney failure — driven by low vitamin D, high phosphate, and low calcium — damaging bones and vessels if untreated.
Active vitamin D (calcitriol, paricalcitol) used to control secondary hyperparathyroidism in CKD.
Blood phosphate above ~5.5 mg/dL - a CKD mineral-bone disorder driver that accelerates vascular calcification and bone disease.
Bone disease caused by chronic kidney disease — abnormal bone turnover from calcium, phosphate, vitamin D, and PTH disturbances.
Advertisement
ZuvFlo is ready to integrate with your facility to streamline operations, automate compliance, and deliver better patient care.
No credit card required • Setup in under 2 hours • Cancel anytime
Advertisement
This content is a general reference, not medical advice, a diagnosis, or a treatment plan. Do not change your diet, fluids, medicines, or dialysis plan without your nephrologist or renal dietitian. Individual recommendations depend on your labs, medications, conditions, and care plan.